Israeli genomics company NRGene bringing U.S. headquarters to St. Louis
ST. LOUIS — An Israeli genomics company has chosen St. Louis for the location of its U.S. headquarters, the St. Louis Business Journal reported.
Check out jobs at NRGene here.
NRGene, which develops tools that use big data to identify genetic traits to improve crop yield and disease resistance, will open at the CIC@CET building in the Cortex innovation district in Midtown, officials with BioSTL said Friday. The local office will have a staff of six led by Paul Chomet.
NRGene is the fourth Israeli company to move to St. Louis through BioSTL’s GlobalSTL initiative to attract high-growth international companies. Kaiima Agro-Biotech, Evogene and Forrest Innovations also came to St. Louis through the initiative. GlobalSTL began in 2014 as the St. Louis-Israel Innovation Connection (SLIIC) and initially focused on Israel.
NRGene, the first to successfully assemble the whole genome sequence for wheat, has assembled more than 80 genomes in under a year, officials said.
Source: St. Louis Business Journal